Pharvaris (PHVS) Institutional Ownership → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free PHVS Stock Alerts $20.35 -1.36 (-6.26%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Pharvaris (NASDAQ:PHVS)Number ofInstitutional Buyers(last 12 months)11TotalInstitutional Inflows(last 12 months)$141.47MNumber ofInstitutional Sellers(last 12 months)6TotalInstitutional Outflows(last 12 months)$64.52M Get PHVS Insider Trade Alerts Want to know when executives and insiders are buying or selling Pharvaris stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PHVS Institutional Buying and Selling by Quarter Ad Weiss RatingsThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. Pharvaris Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2024 Bain Capital Life Sciences Investors LLC3,303,381$76.34M6.1%-15.4%0.000% 5/15/2024 venBio Partners LLC4,289,304$99.13M35.2%-12.8%0.000% 5/15/2024 Price T Rowe Associates Inc. MD757,915$17.52M0.0%-10.1%0.000% 2/15/2024 Blackstone Inc.100,000$2.81M0.0%N/A0.314% 2/14/2024 venBio Partners LLC4,919,504$137.99M20.7%+15.4%15.451% 2/14/2024 Commodore Capital LP800,000$22.44M2.0%N/A2.513% Get the Latest News and Ratings for PHVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pharvaris and its competitors with MarketBeat's FREE daily newsletter. 2/13/2024 Bain Capital Life Sciences Investors LLC3,904,319$109.52M10.5%-18.4%0.000% 2/7/2024 Vivo Capital LLC285,000$7.99M0.7%N/A0.000% 12/7/2023 Hudson Bay Capital Management LP38,893$812K0.0%N/A0.122% 11/21/2023 Walleye Capital LLC81,017$1.69M0.0%+15.2%0.254% 11/13/2023 Foresite Capital Management V LLC33,142$692K1.1%-2.9%0.000% 11/13/2023 FMR LLC3,207,564$66.94M0.0%-5.3%0.000% 8/15/2023 Silverarc Capital Management LLC200,000$3.03M0.9%-64.2%0.000% 8/15/2023 Bain Capital Life Sciences Investors LLC4,868,784$73.71M7.6%+53.1%0.000% 8/14/2023 Cormorant Asset Management LP973,614$14.74M0.8%+19.2%0.000% 8/11/2023 VR Adviser LLC1,326,200$20.08M3.2%N/A0.000% 8/11/2023 General Atlantic L.P.4,406,252$66.71M1.1%+82.1%0.000% 8/11/2023 Foresite Capital Management IV LLC3,743,450$56.68M27.9%+15.3%0.000% 5/15/2023 Sio Capital Management LLC228,385$1.84M0.9%-19.9%0.717% 11/14/2022 Cormorant Asset Management LP1,207,500$9.26M0.6%+5.4%3.792% 11/14/2022Pictet Asset Management SA399,875$3.21M0.0%-13.6%1.256% 8/16/2022 venBio Partners LLC2,301,451$50.86M14.5%-0.1%7.228% 8/16/2022 Deerfield Management Company L.P. Series C1,190,343$26.31M0.5%-24.5%3.739% 8/9/2022Pictet Asset Management SA462,630$10.22M0.0%-14.0%1.453% 5/17/2022 Eventide Asset Management LLC302,619$5.66M0.1%+23.6%0.950% 5/16/2022 Deerfield Management Company L.P. Series C1,577,078$28.60M0.6%-0.3%4.953% 5/16/2022 Viking Global Investors LP2,480,319$46.38M0.2%+1.0%7.790% 2/14/2022 Deerfield Management Company L.P. Series C1,581,331$22.76M0.5%-1.7%4.966% 2/14/2022 Suvretta Capital Management LLC827,540$11.91M0.2%N/A2.599% 2/14/2022 DAFNA Capital Management LLC36,720$528K0.1%+4.7%0.115% 2/14/2022 Novo Holdings A S516,321$7.43M0.4%+23.2%1.622% 2/10/2022Pictet Asset Management SA540,811$8.56M0.0%-2.9%1.699% 11/16/2021 VR Adviser LLC552,882$9.80M1.3%-38.8%1.736% 11/16/2021 Millennium Management LLC157,753$2.72M0.0%-19.9%0.495% 11/15/2021 Deerfield Management Company L.P. Series C1,608,471$28.52M0.6%+55.7%5.052% 11/10/2021 Goldman Sachs Group Inc.30,174$535K0.0%+8.6%0.095% 10/28/2021 Compagnie Lombard Odier SCmA16,670$287K0.0%+10.9%0.052% 8/17/2021 Millennium Management LLC196,967$3.58M0.0%-14.7%0.619% 8/17/2021 Caas Capital Management LP13,479$251K0.0%-73.0%0.042% 8/16/2021 Opaleye Management Inc.79,837$1.49M0.2%N/A0.251% Elon’s New Device is About to Shock the World (Ad)Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake.8/16/2021 Goldman Sachs Group Inc.27,792$518K0.0%+13.8%0.087% 8/13/2021 Geode Capital Management LLC18,643$338K0.0%+13.8%0.059% 8/13/2021 FMR LLC3,258,217$59.20M0.0%+17.7%10.233% 8/12/2021 JPMorgan Chase & Co.16,434$299K0.0%+18.5%0.052% 6/10/2021 Perceptive Advisors LLC27,000$755K0.0%N/A0.085% 5/27/2021Davidson Kempner Capital Management LP3,500$98K0.0%N/A0.011% 5/19/2021 venBio Partners LLC2,303,310$64.45M6.1%N/A7.234% 5/18/2021 Millennium Management LLC230,900$6.48M0.0%N/A0.725% 5/18/2021 Zimmer Partners LP15,000$420K0.0%N/A0.047% 5/18/2021 Cormorant Asset Management LP864,143$23.81M0.5%N/A2.714% 5/18/2021Davidson Kempner Capital Management LP3,500$98K0.0%N/A0.011% 5/17/2021 Viking Global Investors LP2,420,155$67.91M0.2%N/A7.601% 5/17/2021 Deerfield Management Company L.P. Series C1,032,757$28.90M0.6%N/A3.244% 5/17/2021 Perceptive Advisors LLC27,000$755K0.0%N/A0.085% 5/17/2021 General Atlantic LLC2,420,155$67.72M0.8%N/A7.601% 5/17/2021 Caas Capital Management LP50,000$1.40M0.0%N/A0.157% 5/17/2021Pinz Capital Management LP22,650$634K0.2%N/A0.071% 5/17/2021 Novo Holdings A S50,000$1.40M0.1%N/A0.157% 5/17/2021 Goldman Sachs Group Inc.24,428$683K0.0%N/A0.077% 5/13/2021 Rokos Capital Management LLP2,500$68K0.0%N/A0.008% 5/12/2021 Geode Capital Management LLC16,384$459K0.0%N/A0.051% 5/12/2021 Ensign Peak Advisors Inc5,000$140K0.0%N/A0.016% 5/12/2021 JPMorgan Chase & Co.13,874$389K0.0%N/A0.044% 5/7/2021 BlackRock Inc.33,382$934K0.0%N/A0.105% (Data available from 1/1/2016 forward) PHVS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PHVS shares? During the previous two years, 18 institutional investors and hedge funds held shares of Pharvaris. The most heavily invested institutionals were venBio Partners LLC ($99.13M), Bain Capital Life Sciences Investors LLC ($76.34M), FMR LLC ($66.94M), General Atlantic L.P. ($66.71M), Foresite Capital Management IV LLC ($56.68M), Deerfield Management Company L.P. Series C ($26.31M), and Commodore Capital LP ($22.44M).Learn more on PHVS's institutional investors. Which institutional investors have been buying Pharvaris stock? Of the 11 institutional investors that purchased Pharvaris stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: General Atlantic L.P. ($1.99M), Bain Capital Life Sciences Investors LLC ($1.69M), VR Adviser LLC ($1.33M), Commodore Capital LP ($800K), venBio Partners LLC ($654.83K), Foresite Capital Management IV LLC ($496.52K), and Vivo Capital LLC ($285K). How much institutional buying is happening at Pharvaris? Institutional investors have bought a total of 7,605,121 shares in the last 24 months. This purchase volume represents approximately $141.94M in transactions. Which Pharvaris major shareholders have been selling company stock? Of the 9 institutional investors that sold Pharvaris stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Bain Capital Life Sciences Investors LLC ($1.48M), venBio Partners LLC ($632.06K), Deerfield Management Company L.P. Series C ($386.74K), Silverarc Capital Management LLC ($359.39K), FMR LLC ($179.59K), Pictet Asset Management SA ($137.76K), and Price T Rowe Associates Inc. MD ($84.78K). How much institutional selling is happening at Pharvaris? Institutional investors have sold a total of 3,319,220 shares in the last 24 months. This volume of shares sold represents approximately $75.70M in transactions. Related Companies: Grifols Major Shareholders LAVA Therapeutics Major Shareholders NLS Pharmaceutics Major Shareholders Procaps Group Major Shareholders Alpha Tau Medical Major Shareholders Alvotech Major Shareholders American Oncology Network Major Shareholders BriaCell Therapeutics Major Shareholders BrightSpring Health Services Major Shareholders Bullfrog AI Major Shareholders This page (NASDAQ:PHVS) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharvaris Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
